Designer exosomes as next-generation cancer immunotherapy

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 12, Issue 1, 2016, Pages 163-169

  Bell, Brandon M ^a   Kirk, Isabel D ^a   Hiltbrunner, Stefanie ^b   Gabrielsson, Susanne ^b   Bultema, Jarred J ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOENGINEERING; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; EXOSOME; HUMAN; SCIENTIST; ANIMAL; DRUG DESIGN; GENETIC ENGINEERING; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; NEOPLASMS; PROCEDURES;

CANCER VACCINE;

ANIMALS; CANCER VACCINES; DRUG DESIGN; EXOSOMES; GENETIC ENGINEERING; HUMANS; IMMUNOTHERAPY; NEOPLASMS;

EID: 84957086079     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2015.09.011     Document Type: Note

References (81)

1. Colombo M., Raposo G., Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 2014, 30:255-289.
2. Zwicker J.I., Liebman H.A., Neuberg D., Lacroix R., Bauer K.A., Furie B.C., et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 2009, 15(22):6830-6840.
3. Vojtech L., Woo S., Hughes S., Levy C., Ballweber L., Sauteraud R.P., et al. Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions. Nucleic Acids Res 2014, 42(11):7290-7304.
4. Trajkovic K., Hsu C., Chiantia S., Rajendran L., Wenzel D., Wieland F., et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008, 319(5867):1244-1247.
5. Batista B.S., Eng W.S., Pilobello K.T., Hendricks-Muñoz K.D., Mahal L.K. Identification of a conserved glycan signature for microvesicles. J Proteome Res 2011, 10(10):4624-4633.
6. Roucourt B., Meeussen S., Bao J., Zimmermann P., David G. Heparanase activates the syndecan-syntenin-ALIX exosome pathway. Cell Res 2015, 25(4):412-428.
7. Liang Y., Eng W.S., Colquhoun D.R., Dinglasan R.R., Graham D.R., Mahal L.K. Complex N-linked glycans serve as a determinant for exosome/microvesicle cargo recruitment. J Biol Chem 2014, 289(47):32526-32537.
8. Colombo M., Moita C., van Niel G., Kowal J., Vigneron J., Benaroch P., et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci 2013, 126(Pt 24):5553-5565.
9. Ostrowski M., Carmo N.B., Krumeich S., Fanget I., Raposo G., Savina A., et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 2010, 12(1):1-13.
10. Hsu C., Morohashi Y., Yoshimura S.-I., Manrique-Hoyos N., Jung S., Lauterbach M.A., et al. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J Cell Biol 2010, 189(2):223-232.
11. Savina A., Fader C.M., Damiani M.T., Colombo M.I. Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic 2005, 6(2):131-143.
12. Welz T., Wellbourne-Wood J., Kerkhoff E. Orchestration of cell surface proteins by Rab11. Trends Cell Biol 2014, 24(7):407-415.
13. Chaineau M., Ioannou M.S., McPherson P.S. Rab35: GEFs, GAPs and effectors. Traffic 2013, 14(11):1109-1117.
14. Fukuda M. Rab27 effectors, pleiotropic regulators in secretory pathways. Traffic 2013, 14(9):949-963.
15. Tarafder A.K., Bolasco G., Correia M.S., Pereira F.J.C., Iannone L., Hume A.N., et al. Rab11b mediates melanin transfer between donor melanocytes and acceptor keratinocytes via coupled exo/endocytosis. J Invest Dermatol 2014, 134(4):1056-1066.
16. Bultema J.J., Ambrosio A.L., Burek C.L., Di Pietro S.M. BLOC-2, AP-3, and AP-1 proteins function in concert with Rab38 and Rab32 proteins to mediate protein trafficking to lysosome-related organelles. J Biol Chem 2012, 287(23):19550-19563.
17. Bultema J.J., Boyle J.A., Malenke P.B., Martin F.E., Dell'Angelica E.C., Cheney R.E., et al. Myosin vc interacts with Rab32 and Rab38 proteins and works in the biogenesis and secretion of melanosomes. J Biol Chem 2014, 289(48):33513-33528.
18. Valiunas V., Wang H.-Z., Li L., Gordon C., Valiuniene L., Cohen I.S., et al. A comparison of two cellular delivery mechanisms for small interfering RNA. Physiol Rep 2015, 1:3(2).
19. Smyth T.J., Redzic J.S., Graner M.W., Anchordoquy T.J. Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro. Biochim Biophys Acta 2014, 1838(11):2954-2965.
20. Wiklander O.P.B., Nordin J.Z., O'Loughlin A., Gustafsson Y., Corso G., Mäger I., et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles 2015, 4:26316.
21. Saunderson S.C., Dunn A.C., Crocker P.R., McLellan A.D. CD169 mediates the capture of exosomes in spleen and lymph node. Blood 2014, 123(2):208-216.
22. Segura E., Guérin C., Hogg N., Amigorena S., Théry C. CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo. J Immunol 2007, 179(3):1489-1496.
23. Christianson H.C., Svensson K.J., van Kuppevelt T.H., Li J.-P., Belting M. Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc Natl Acad Sci U S A 2013, 110(43):17380-17385.
24. Franzen C.A., Simms P.E., Van Huis A.F., Foreman K.E., Kuo P.C., Gupta G.N. Characterization of uptake and internalization of exosomes by bladder cancer cells. BioMed Res Int 2014, 2014:619829.
25. Mulcahy L.A., Pink R.C., Carter D.R.F. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles 2014, 3. 10.3402/jev.v3.24641.
26. Nordin J.Z., Lee Y., Vader P., Mäger I., Johansson H.J., Heusermann W., et al. Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties. Nanomed Nanotechnol Biol Med 2015, 11(4):879-883.
27. Choi D.-S., Kim D.-K., Kim Y.-K., Gho Y.S. Proteomics, transcriptomics and lipidomics of exosomes and ectosomes. Proteomics 2013, 13(10-11):1554-1571.
28. Llorente A., Skotland T., Sylvänne T., Kauhanen D., Róg T., Orłowski A., et al. Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Biochim Biophys Acta 2013, 1831(7):1302-1309.
29. Subra C., Laulagnier K., Perret B., Record M. Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. Biochimie 2007, 89(2):205-212.
30. Valadi H., Ekström K., Bossios A., Sjöstrand M., Lee J.J., Lötvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9(6):654-659.
31. Ratajczak J., Miekus K., Kucia M., Zhang J., Reca R., Dvorak P., et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006, 20(5):847-856.
32. Mizrak A., Bolukbasi M.F., Ozdener G.B., Brenner G.J., Madlener S., Erkan E.P., et al. Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth. Mol Ther 2013, 21(1):101-108.
33. Ekström K., Valadi H., Sjöstrand M., Malmhäll C., Bossios A., Eldh M., et al. Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells. J Extracell Vesicles 2012, 10.3402/jev.v1i0.18389.
34. Gibbings D.J., Ciaudo C., Erhardt M., Voinnet O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 2009, 11(9):1143-1149.
35. Pegtel D.M., Cosmopoulos K., Thorley-Lawson D.A., van Eijndhoven M.A.J., Hopmans E.S., Lindenberg J.L., et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A 2010, 107(14):6328-6333.
36. Alvarez-Erviti L., Seow Y., Yin H., Betts C., Lakhal S., Wood M.J.A. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011, 29(4):341-345.
37. EL Andaloussi S., Mäger I., Breakefield X.O., Wood M.J.A. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 2013, 12(5):347-357.
38. Bolukbasi M.F., Mizrak A., Ozdener G.B., Madlener S., Ströbel T., Erkan E.P., et al. miR-1289 and "zipcode"-like sequence enrich mRNAs in microvesicles. Mol Ther Nucleic Acids 2012, 1:e10.
39. Kanada M., Bachmann M.H., Hardy J.W., Frimannson D.O., Bronsart L., Wang A., et al. Differential fates of biomolecules delivered to target cells via extracellular vesicles. Proc Natl Acad Sci U S A 2015, 10.1073/pnas.1418401112.
40. Fuhrmann G., Serio A., Mazo M., Nair R., Stevens M.M. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release 2015, 205:35-44.
41. Yang T., Martin P., Fogarty B., Brown A., Schurman K., Phipps R., et al. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Pharm Res 2015, 32(6):2003-2014.
42. Gehrmann U., Näslund T.I., Hiltbrunner S., Larssen P., Gabrielsson S. Harnessing the exosome-induced immune response for cancer immunotherapy. Semin Cancer Biol 2014, 28:58-67.
43. Pitt J.M., Charrier M., Viaud S., André F., Besse B., Chaput N., et al. Dendritic cell-derived exosomes as immunotherapies in the fight against cancer. J Immunol 2014, 193(3):1006-1011.
44. Andre F., Schartz N.E.C., Movassagh M., Flament C., Pautier P., Morice P., et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 2002, 360(9329):295-305.
45. Colino J., Snapper C.M. Exosomes from bone marrow dendritic cells pulsed with diphtheria toxoid preferentially induce type 1 antigen-specific IgG responses in naive recipients in the absence of free antigen. J Immunol 2006, 177(6):3757-3762.
46. Théry C., Regnault A., Garin J., Wolfers J., Zitvogel L., Ricciardi-Castagnoli P., et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol 1999, 147(3):599-610.
47. Sheng K.-C., Day S., Wright M.D., Stojanovska L., Apostolopoulos V. Enhanced dendritic cell-mediated antigen-specific CD4+ T cell responses: IFN-gamma aids TLR stimulation. J Drug Deliv 2013, 2013:516749.
48. Raposo G., Nijman H.W., Stoorvogel W., Liejendekker R., Harding C.V., Melief C.J., et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996, 183(3):1161-1172.
49. Viaud S., Terme M., Flament C., Taieb J., André F., Novault S., et al. Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. PLoS One 2009, 4(3):e4942.
50. Zitvogel L., Regnault A., Lozier A., Wolfers J., Flament C., Tenza D., et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 1998, 4(5):594-600.
51. Segura E., Nicco C., Lombard B., Véron P., Raposo G., Batteux F., et al. ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood 2005, 106(1):216-223.
52. Nolte-'t Hoen E.N.M., van der Vlist E.J., de Boer-Brouwer M., Arkesteijn G.J.A., Stoorvogel W., Wauben M.H.M. Dynamics of dendritic cell-derived vesicles: high-resolution flow cytometric analysis of extracellular vesicle quantity and quality. J Leukoc Biol 2013, 93(3):395-402.
53. Näslund T.I., Gehrmann U., Qazi K.R., Karlsson M.C.I., Gabrielsson S. Dendritic cell-derived exosomes need to activate both T and B cells to induce antitumor immunity. J Immunol 2013, 190(6):2712-2719.
54. Escudier B., Dorval T., Chaput N., André F., Caby M.-P., Novault S., et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J Transl Med 2005, 3(1):10.
55. Poschke I., Mougiakakos D., Kiessling R. Camouflage and sabotage: tumor escape from the immune system. Cancer Immunol Immunother 2011, 60(8):1161-1171.
56. Mu W., Rana S., Zöller M. Host matrix modulation by tumor exosomes promotes motility and invasiveness. Neoplasia 2013, 15(8):875-887.
57. Chowdhury R., Webber J.P., Gurney M., Mason M.D., Tabi Z., Clayton A. Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts. Oncotarget 2015, 6(2):715-731.
58. Hood J.L., San R.S., Wickline S.A. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res 2011, 71(11):3792-3801.
59. Safaei R., Larson B.J., Cheng T.C., Gibson M.A., Otani S., Naerdemann W., et al. Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther 2005, 4(10):1595-1604.
60. Hsu D.-H., Paz P., Villaflor G., Rivas A., Mehta-Damani A., Angevin E., et al. Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides. J Immunother 2003, 26(5):440-450.
61. Qazi K.R., Gehrmann U., Domange Jordö E., Karlsson M.C.I., Gabrielsson S. Antigen-loaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism. Blood 2009, 113(12):2673-2683.
62. Morse M.A., Garst J., Osada T., Khan S., Hobeika A., Clay T.M., et al. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med 2005, 3(1):9.
63. Viaud S., Théry C., Ploix S., Tursz T., Lapierre V., Lantz O., et al. Dendritic cell-derived exosomes for cancer immunotherapy: what's next?. Cancer Res 2010, 70(4):1281-1285.
64. Dai S., Wei D., Wu Z., Zhou X., Wei X., Huang H., et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther 2008, 16(4):782-790.
65. Delcayre A., Estelles A., Sperinde J., Roulon T., Paz P., Aguilar B., et al. Exosome display technology: applications to the development of new diagnostics and therapeutics. Blood Cells Mol Dis 2005, 35(2):158-168.
66. Estelles A., Sperinde J., Roulon T., Aguilar B., Bonner C., LePecq J.-B., et al. Exosome nanovesicles displaying G protein-coupled receptors for drug discovery. Int J Nanomedicine 2007, 2(4):751-760.
67. Shen B., Wu N., Yang J.-M., Gould S.J. Protein targeting to exosomes/microvesicles by plasma membrane anchors. J Biol Chem 2011, 286(16):14383-14395.
68. Utsugi-Kobukai S., Fujimaki H., Hotta C., Nakazawa M., Minami M. MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells. Immunol Lett 2003, 89(2-3):125-131.
69. Ghosh A., Davey M., Chute I.C., Griffiths S.G., Lewis S., Chacko S., et al. Rapid isolation of extracellular vesicles from cell culture and biological fluids using a synthetic peptide with specific affinity for heat shock proteins. PLoS One 2014, 9(10):e110443.
70. El Andaloussi S., Lakhal S., Mäger I., Wood M.J.A. Exosomes for targeted siRNA delivery across biological barriers. Adv Drug Deliv Rev 2013, 65(3):391-397.
71. Hung M.E., Leonard J.N. Stabilization of exosome targeting peptides via engineered glycosylation. J Biol Chem 2015, 290(13):8166-8172.
72. Véron P., Segura E., Sugano G., Amigorena S., Théry C. Accumulation of MFG-E8/lactadherin on exosomes from immature dendritic cells. Blood Cells Mol Dis 2005, 35(2):81-88.
73. Viaud S., Ploix S., Lapierre V., Théry C., Commere P.-H., Tramalloni D., et al. Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-γ. J Immunother 2011, 34(1):65-75.
74. Montecalvo A., Larregina A.T., Shufesky W.J., Stolz D.B., Sullivan M.L.G., Karlsson J.M., et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 2012, 119(3):756-766.
75. Gehrmann U., Hiltbrunner S., Georgoudaki A.-M., Karlsson M.C., Näslund T.I., Gabrielsson S. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes. Cancer Res 2013, 73(13):3865-3876.
76. Van der Meel R., Fens M.H.A.M., Vader P., van Solinge W.W., Eniola-Adefeso O., Schiffelers R.M. Extracellular vesicles as drug delivery systems: lessons from the liposome field. J Control Release 2014, 195:72-85.
77. Li K., Chang S., Wang Z., Zhao X., Chen D. A novel micro-emulsion and micelle assembling method to prepare DEC205 monoclonal antibody coupled cationic nanoliposomes for simulating exosomes to target dendritic cells. Int J Pharm 2015, 491(1-2):105-112.
78. Jang S.C., Kim O.Y., Yoon C.M., Choi D.-S., Roh T.-Y., Park J., et al. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano 2013, 7(9):7698-7710.
79. Moon J.J., Huang B., Irvine D.J. Engineering nano- and microparticles to tune immunity. Adv Mater 2012, 24(28):3724-3746.
80. Pawelek J.M., Chakraborty A.K., Rachkovsky M.L., Orlow S.J., Bolognia J.L., Sodi S.A. Altered N-glycosylation in macrophage x melanoma fusion hybrids. Cell Mol Biol 1999, 45(7):1011-1027.
81. Theos A.C., Truschel S.T., Tenza D., Hurbain I., Harper D.C., Berson J.F., et al. A lumenal domain-dependent pathway for sorting to intralumenal vesicles of multivesicular endosomes involved in organelle morphogenesis. Dev Cell 2006, 10(3):343-354.